JPS6145637B2 - - Google Patents

Info

Publication number
JPS6145637B2
JPS6145637B2 JP52061704A JP6170477A JPS6145637B2 JP S6145637 B2 JPS6145637 B2 JP S6145637B2 JP 52061704 A JP52061704 A JP 52061704A JP 6170477 A JP6170477 A JP 6170477A JP S6145637 B2 JPS6145637 B2 JP S6145637B2
Authority
JP
Japan
Prior art keywords
alkyl
acid
dht
atoms
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52061704A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52148060A (en
Inventor
Fuan Deru Fuiisu Yohanesu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS52148060A publication Critical patent/JPS52148060A/ja
Publication of JPS6145637B2 publication Critical patent/JPS6145637B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6170477A 1976-05-28 1977-05-25 17 betaaester of testosterone and alphaa dihydrotestosterone Granted JPS52148060A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (2)

Publication Number Publication Date
JPS52148060A JPS52148060A (en) 1977-12-08
JPS6145637B2 true JPS6145637B2 (OSRAM) 1986-10-08

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6170477A Granted JPS52148060A (en) 1976-05-28 1977-05-25 17 betaaester of testosterone and alphaa dihydrotestosterone

Country Status (12)

Country Link
JP (1) JPS52148060A (OSRAM)
AR (1) AR214323A1 (OSRAM)
BE (1) BE855163A (OSRAM)
CH (1) CH627761A5 (OSRAM)
DE (1) DE2723876C2 (OSRAM)
DK (1) DK146096C (OSRAM)
ES (1) ES459230A1 (OSRAM)
FI (1) FI57597C (OSRAM)
FR (1) FR2352832A1 (OSRAM)
GB (1) GB1567515A (OSRAM)
NL (1) NL7705790A (OSRAM)
SE (1) SE425493B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004506698A (ja) * 2000-08-23 2004-03-04 アクゾ・ノベル・エヌ・ベー ヒトに用いるためのテストステロンエステル製剤
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) * 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. TESTOSTERONE UNDECANOATE ORAL TREATMENT
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
GB1567515A (en) 1980-05-14
SE7706235L (sv) 1977-11-29
FR2352832B1 (OSRAM) 1980-07-11
FI57597C (fi) 1980-09-10
DK146096B (da) 1983-06-27
FI57597B (fi) 1980-05-30
NL7705790A (nl) 1977-11-30
DE2723876A1 (de) 1977-12-15
ES459230A1 (es) 1978-11-16
SE425493B (sv) 1982-10-04
FR2352832A1 (fr) 1977-12-23
BE855163A (fr) 1977-11-28
AR214323A1 (es) 1979-05-31
DK146096C (da) 1983-11-21
CH627761A5 (en) 1982-01-29
JPS52148060A (en) 1977-12-08
FI771684A7 (OSRAM) 1977-11-29
DK236877A (da) 1977-11-29
DE2723876C2 (de) 1986-10-30

Similar Documents

Publication Publication Date Title
US4147783A (en) Oral pharmaceutical preparation
US4083973A (en) Pharmaceutical preparation adapted for oral administration
US4071623A (en) Pharmaceutical preparation adapted for oral administration
US4220599A (en) Oral pharmaceutical preparation having androgenic activity
US4098802A (en) Oral pharmaceutical preparation having androgenic activity
KR0167613B1 (ko) 사이클로스포린-함유 연질캅셀제 조성물
CA2722408C (en) Lipid composition for enhancing steroid solubility
US4851439A (en) Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
US4746675A (en) External pharmaceutical composition
US5149695A (en) Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
JPH0276819A (ja) 脂肪酸組成物
JPS6296422A (ja) 子宮内膜増殖症予防または治療用組成物の製造方法およびその来成物を用いる前記増殖症の予防または治療方法
JP2000510458A (ja) 医薬用組成物
NO20005431D0 (no) Gelérbare farmasøytiske preparater
US4260603A (en) Sterol glycoside with activity as prostaglandin synthetase inhibitor
JPH11512115A (ja) 経口投与用製剤組成物
JPS6145637B2 (OSRAM)
IL37026A (en) Pharmaceutical preparations containing vitamin a derivatives
US4842865A (en) Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules
KR19990076462A (ko) 사이클로스포린-함유 마이크로에멀젼 예비농축액 조성물
KR100347862B1 (ko) 안티글루코코르티코이드약제
US4681875A (en) 3,17 β-estriol diesters, methods of their use, and pharmaceutical preparations containing them
KR20050084572A (ko) 스테롤 및/또는 스탄올 및 특정한 종류의 항염증제를포함하는 유도체, 및 심혈관 질환을 치료 또는 예방하는이들의 용도
JPH0112729B2 (OSRAM)
CA1113926A (en) Pharmaceutical preparation adapted for oral administration